Anne Monette

1.8k citations
28 papers · 839 indexed · h-index 15
Topics
RNA Research and Splicing (11 papers)HIV Research and Treatment (9 papers)Cancer Immunotherapy and Biomarkers (5 papers)
Partner nations
CanadaUnited StatesChile

In The Last Decade

Anne Monette

27 papers receiving 821 citations

Peers

Anne Monette
Comparison fields: 5 of 93
  • Molecular Biology 496
  • Virology 166
  • Cardiology and Cardiovascular Medicine 140
  • Immunology 130
  • Infectious Diseases 97
Replace Séverine Loisel‐Meyer with:
Séverine Loisel‐Meyer France
Xiaojun Hu China
Husain Attarwala United States
Sun D China
Eleonora Vecchio Italy
Jingying Zhou China
Krisztina Kerekes Hungary
Unni Nonstad Norway
Arun Pradhan United States
Anne Monette relative to Séverine Loisel‐Meyer France Séverine Loisel‐Meyer's profile →
Citations per field
00.5×9.3×
Séverine Loisel‐Meyer · 1×
Citations per year

Countries citing papers authored by Anne Monette

Since Specialization
Citations

This map shows the geographic impact of Anne Monette's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Monette with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Monette more than expected).

Fields of papers citing papers by Anne Monette

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne Monette. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Monette. The network helps show where Anne Monette may publish in the future.

Co-authorship network of co-authors of Anne Monette

This figure shows the co-authorship network connecting the top 25 collaborators of Anne Monette. A scholar is included among the top collaborators of Anne Monette based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne Monette. Anne Monette is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 8
2 6
3 23
4 1
5 14
6 70
7 4
8 9
9 19
10 25
11 5
12 1
13 29
14 115
15 41
16 17
17 62
18 101
19 83
20 134

About Anne Monette

Anne Monette is a scholar working on Virology, Oncology and Cancer Research, having authored 28 papers that have together received 839 indexed citations. Recurring topics across this work include RNA Research and Splicing (11 papers), HIV Research and Treatment (9 papers) and Cancer Immunotherapy and Biomarkers (5 papers). The work is most often cited by research in Virology (166 citations), Molecular Biology (496 citations) and Immunology (130 citations). Anne Monette has collaborated with scholars based in Canada, United States and Chile. Frequent co-authors include Andrew J. Mouland, Marcelo López‐Lastra, Lara Ajamian, Réjean Lapointe, Sophie Lerouge, Caroline Ceccaldi, Elias Assaad, Jacques Galipeau, Mark Blostein and Daniel L. Coutu. Their work appears in journals such as Nucleic Acids Research, Journal of Biological Chemistry and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026